Defects on regulators of disease-causing proteins can cause neurological disease

February 22, 2018, Baylor College of Medicine

When the protein Ataxin1 accumulates in neurons it causes a neurological condition called spinocerebellar ataxia type 1 (SCA1), a disease characterized by progressive problems with balance. Ataxin1 accumulates because of a mutation that produces an abnormal, very long version of the protein that forms clumps inside neurons. However, studies on animal models have shown that accumulation of normal, regular-length Ataxin1 can lead to neurodegeneration similar to SCA1. In this case, the problem was a mutation in one of the genes that regulate Ataxin1 production, called Pumilio1, that resulted in overproduction of normal Ataxin1. Inspired by the findings in animal models, an international team of researchers explored the possibility that a similar phenomenon happened in people. They report in the journal Cell that mutations in human PUMILIO1 gene also cause conditions similar to SCA1. These findings provide a better understanding of the genetic basis of neurological diseases and suggest that identifying protein regulators would single out new candidates for disease-causing genes.

"In this study, we investigated the possibility that our findings in mice—that mutations in Ataxin1 regulator Pumilio1 cause a neurological disease similar to SCA1—would translate to people," said first author Dr. Vincenzo Gennarino, a postdoctoral fellow in Dr. Huda Zoghbi's lab at Baylor College of Medicine during the development of this work, and currently an assistant professor of genetics and development at Columbia University Medical Center.

The amount of a single protein can affect the manifestation of a disease

The researchers began by searching for patients with symptoms similar to those of SCA1 in large genomic databases around the world. They identified 15 patients with different mutations of PUMILIO1 gene, which they separated into two groups. In one group, the amount of PUMILIO1 was about half that detected in people without the condition. These patients presented with a severe form of the disease that had started early, between 5 months and 1 year of age. The children have seizures, ataxia, poor motor coordination and developmental delay. In the other group of patients, the amount of PUMILIO1 was 75 percent of that present in individuals without the condition. These patients presented with a milder form of ataxia that appeared in their 40s or 50s.

"This study, which is a nice example of the power of collaborations, taught us that mutations in the same gene can cause vastly different neurological problems based on how much they compromise the protein product," said corresponding author Dr. Huda Zoghbi, professor of molecular and human genetics and of pediatrics and neuroscience at Baylor and director of the Jan and Dan Duncan Neurological Research Institute. Zoghbi also is an investigator at the Howard Hughes Medical Institute.

"We found these findings very exciting," Gennarino said. "We learned that the characteristics of the disease vary according to the levels of PUMILIO1 protein. We used to think that modest changes in the levels of certain proteins, such as a 25 percent deficiency, had no detrimental effect on the individual. Here we found that this is not the case. This is an important finding from the clinical point of view. An individual born with a 25 percent deficiency of PUMILIO1 or perhaps other proteins may only develop symptoms later in life."

These findings also have implications for other neurodegenerative conditions such as Alzheimer's disease, , or Lou Gehrig's disease, and Parkinson's disease. Identifying the regulators of proteins involved in these diseases would provide a list of candidate genes potentially linked to the condition and open new venues for novel therapeutic strategies.

"We hope that this study encourages other researchers to look back at their own studies from the perspective of the regulators of protein synthesis or clearance," Gennarino said.

Explore further: Exercise provides clue to deadly ataxia

More information: Cell (2018). DOI: 10.1016/j.cell.2018.02.006

Related Stories

Exercise provides clue to deadly ataxia

November 3, 2011
When Dr. John Fryer and Dr. Huda Zoghbi prescribed mild exercise for mice with a neurodegenerative disorder called spinocerebellar ataxia 1 (SCA1), they did not know what to expect.

Protein YAP in early life influences adult spinocerebellar ataxia pathology

January 25, 2018
Spinocerebellar ataxia is a group of neurodegenerative diseases characterized by progressive incoordination of gait, and is often associated with poor coordination of hands, speech and eye movements. There are different types ...

New structural insight into neurodegenerative disease

March 14, 2013
A research team from the Korea Advanced Institute of Science and Technology (KAIST) released their results on the structure and molecular details of the neurodegenerative disease-associated protein Ataxin-1. Mutations in ...

A little less protein may be the answer in neurodegenerative disorders

May 29, 2013
In some neurodegenerative diseases, and specifically in a devastating inherited condition called spinocerebellar ataxia 1 (SCA1), the answer may not be an "all-or-nothing," said a collaboration of researchers from Baylor ...

Test reveals potential treatments for disorders involving MeCP2

August 23, 2017
Having twice the normal amount of the protein MeCP2, a condition called MECP2 duplication syndrome, causes severe progressive neuropsychiatric disorders that include intellectual disability, autism spectrum disorders, motor ...

Research provides new understanding of Parkinson's and Alzheimer's disease and opens path to treatment

October 26, 2016
A team of scientists at Baylor College of Medicine and Texas Children's Hospital has discovered that in three separate laboratory models, the protein TRIM28 can promote the accumulation of two key proteins that drive the ...

Recommended for you

Scientists cut main heart disease risk locus out of DNA by genome editing

December 6, 2018
Over the past decade we've learned that billions of people carry a mysterious specter in their DNA that strongly increases their risk for life threatening cardiovascular diseases, such as heart attacks, aneurysms or strokes, ...

What can a snowflake teach us about how cancer spreads in the body?

December 6, 2018
What can seashells, lightning and the coastline of Britain teach us about new drugs for cancer?

New genetic insight could help treat rare debilitating heart and lung condition

December 6, 2018
The largest study of genetic variation in patients with pulmonary arterial hypertension has associated two important genes with the disease.

Are scientists studying the wrong kind of mice?

December 5, 2018
Mice represent well over half of the non-human subjects of biomedical research, and the vast majority of those mice are inbred. Formed by generation after generation of mating between brothers and sisters, inbred mice are ...

Researchers find evidence of prenatal environment tuning genomic imprinting

December 5, 2018
A team of researchers from the U.S., Australia and Denmark has found evidence of the prenatal environment tuning genomic imprinting. In their paper published in Proceedings of the National Academy of Sciences, the group describes ...

Gene that lets you eat as much as you want holds promise against obesity

December 4, 2018
It sounds too good to be true, but a novel approach that might allow you to eat as much food as you want without gaining weight could be a reality in the near future.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.